GlassScriptPhysician profile
Michael Gilles
NPI 1801209143
$2,815.42
in general payments reported to CMS, 2019-2025
19 companies · $778 in 2025
The $778 reported for 2025 was more than what 80% of Gerontology (Clinical Nurse Specialist) providers received nationally (typical 2025 total: $161).
See the full distribution for Gerontology (Clinical Nurse Specialist)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $29.99 · 2022: $179 · 2023: $508 · 2024: $1,320 · 2025: $778.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,230 · Education: $377.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,229.78 |
| Education | $376.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $583.13 | 2022-2024 | Xarelto |
| Janssen Biotech, INC. | $386.74 | 2024-2025 | Darzalex, Tecvayli, Rybrevant |
| Astellas Pharma US INC | $314.96 | 2021-2024 | |
| Astrazeneca Pharmaceuticals LP | $230.53 | 2024-2025 | Enhertu |
| Takeda Pharmaceuticals U.S.A., INC. | $224.19 | 2023-2024 | Fruzaqla, Iclusig |
| Pfizer INC. | $212.77 | 2023-2024 | |
| Gilead Sciences, INC. | $124.52 | 2024 | |
| Abbvie INC. | $124.27 | 2024 | |
| E.R. Squibb & Sons, L.L.C. | $122.03 | 2025 | Opdivo |
| Seagen INC. | $99.00 | 2025 | |
| Novocure INC. | $92.57 | 2025 | Optune Lua (Novottf-200t) |
| Genmab U.S., INC. | $87.49 | 2025 | Epkinly |
| Regeneron Healthcare Solutions, INC. | $76.50 | 2024 | Libtayo |
| Foundation Medicine, INC. | $34.58 | 2023 | |
| Ipsen Biopharmaceuticals, INC | $27.49 | 2025 | Iqirvo |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $25.63 | 2024 | Enhertu |
| Taiho Oncology, INC. | $17.47 | 2023 | |
| Genentech USA, INC. | $16.17 | 2023 | Venclexta |
| Aveo Pharmaceuticals, INC. | $15.38 | 2023 | Fotivda |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Gilles listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.